Matches in SemOpenAlex for { <https://semopenalex.org/work/W3180879220> ?p ?o ?g. }
- W3180879220 endingPage "e11563" @default.
- W3180879220 startingPage "e11563" @default.
- W3180879220 abstract "This study aimed to explore the prognostic factors and outcomes of patients with neuroendocrine tumors (NETs) of the cervix and to determine appropriate treatment.A single-institution retrospective analysis of 172 patients with NETs was performed based on the new International Federation of Gynecology and Obstetrics (FIGO 2018) staging system.Among the 172 eligible patients, 161 were diagnosed with small cell neuroendocrine carcinoma (SCNEC), six with large cell neuroendocrine carcinoma, four with typical carcinoid tumors and one with SCNEC combined with an atypical carcinoid tumor. According to the FIGO 2018 staging guidelines, 31 were stage I, 66 were stage II, 57 were stage III, and 18 were stage IV. The 5-year survival rates of patients with stage I-IV disease were 74.8%, 56.2%, 41.4% and 0%, respectively. The 5-year progression-free survival rates of patients with stage I-IV disease were 63.8%, 54.5%, 30.8% and 0%, respectively. In the multivariate analysis, advanced FIGO stage, large tumor and older age were identified as independent variables for 5-year survival in patients with stage I-IV disease. FIGO stage, tumor size and para-aortic lymph node metastasis were independent prognostic factors for 5-year progression-free survival in patients with stage I-IV disease. For the patients receiving surgery (n = 108), tumor size and pelvic lymph node metastasis were independent prognostic factors for 5-year survival, and pelvic lymph node metastasis for 5-year progression-free survival. In stage IVB, at least six cycles of chemotherapy (n = 7) was associated with significantly better 2-year OS (83.3% vs. 9.1%, p < 0.001) and 2-year PFS (57.1% vs. 0%, p = 0.01) than fewer than six cycles of chemotherapy(n = 11).Advanced FIGO stage, large tumor, older age and lymph node metastasis are independent prognostic factors for NETs of the cervix. The TP/TC and EP regimens were the most commonly used regimens, with similar efficacies and toxicities. Standardized and complete multimodality treatment may improve the survival of patients with NETs." @default.
- W3180879220 created "2021-07-19" @default.
- W3180879220 creator A5036429622 @default.
- W3180879220 creator A5037989560 @default.
- W3180879220 creator A5042490804 @default.
- W3180879220 creator A5051544481 @default.
- W3180879220 creator A5054308359 @default.
- W3180879220 creator A5056861764 @default.
- W3180879220 creator A5062823224 @default.
- W3180879220 creator A5073052023 @default.
- W3180879220 creator A5075529271 @default.
- W3180879220 creator A5081972026 @default.
- W3180879220 creator A5091632977 @default.
- W3180879220 date "2021-07-06" @default.
- W3180879220 modified "2023-10-12" @default.
- W3180879220 title "Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients" @default.
- W3180879220 cites W1966261847 @default.
- W3180879220 cites W1986563378 @default.
- W3180879220 cites W1992591318 @default.
- W3180879220 cites W1996638523 @default.
- W3180879220 cites W1999382508 @default.
- W3180879220 cites W2001153152 @default.
- W3180879220 cites W2002682545 @default.
- W3180879220 cites W2019056019 @default.
- W3180879220 cites W2037046556 @default.
- W3180879220 cites W2052452945 @default.
- W3180879220 cites W2067014780 @default.
- W3180879220 cites W2070267768 @default.
- W3180879220 cites W2072985845 @default.
- W3180879220 cites W2088529454 @default.
- W3180879220 cites W2088956030 @default.
- W3180879220 cites W2101936607 @default.
- W3180879220 cites W2111187247 @default.
- W3180879220 cites W2137535143 @default.
- W3180879220 cites W2150903375 @default.
- W3180879220 cites W2156999040 @default.
- W3180879220 cites W2164078864 @default.
- W3180879220 cites W2209780488 @default.
- W3180879220 cites W2298298373 @default.
- W3180879220 cites W2410551862 @default.
- W3180879220 cites W2759478962 @default.
- W3180879220 cites W2765341072 @default.
- W3180879220 cites W2799468356 @default.
- W3180879220 cites W2980803985 @default.
- W3180879220 doi "https://doi.org/10.7717/peerj.11563" @default.
- W3180879220 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8269661" @default.
- W3180879220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34268005" @default.
- W3180879220 hasPublicationYear "2021" @default.
- W3180879220 type Work @default.
- W3180879220 sameAs 3180879220 @default.
- W3180879220 citedByCount "7" @default.
- W3180879220 countsByYear W31808792202022 @default.
- W3180879220 countsByYear W31808792202023 @default.
- W3180879220 crossrefType "journal-article" @default.
- W3180879220 hasAuthorship W3180879220A5036429622 @default.
- W3180879220 hasAuthorship W3180879220A5037989560 @default.
- W3180879220 hasAuthorship W3180879220A5042490804 @default.
- W3180879220 hasAuthorship W3180879220A5051544481 @default.
- W3180879220 hasAuthorship W3180879220A5054308359 @default.
- W3180879220 hasAuthorship W3180879220A5056861764 @default.
- W3180879220 hasAuthorship W3180879220A5062823224 @default.
- W3180879220 hasAuthorship W3180879220A5073052023 @default.
- W3180879220 hasAuthorship W3180879220A5075529271 @default.
- W3180879220 hasAuthorship W3180879220A5081972026 @default.
- W3180879220 hasAuthorship W3180879220A5091632977 @default.
- W3180879220 hasBestOaLocation W31808792201 @default.
- W3180879220 hasConcept C121608353 @default.
- W3180879220 hasConcept C126322002 @default.
- W3180879220 hasConcept C143998085 @default.
- W3180879220 hasConcept C146357865 @default.
- W3180879220 hasConcept C151730666 @default.
- W3180879220 hasConcept C2777740455 @default.
- W3180879220 hasConcept C2779013556 @default.
- W3180879220 hasConcept C2779066768 @default.
- W3180879220 hasConcept C2780849966 @default.
- W3180879220 hasConcept C29456083 @default.
- W3180879220 hasConcept C38180746 @default.
- W3180879220 hasConcept C71924100 @default.
- W3180879220 hasConcept C86803240 @default.
- W3180879220 hasConceptScore W3180879220C121608353 @default.
- W3180879220 hasConceptScore W3180879220C126322002 @default.
- W3180879220 hasConceptScore W3180879220C143998085 @default.
- W3180879220 hasConceptScore W3180879220C146357865 @default.
- W3180879220 hasConceptScore W3180879220C151730666 @default.
- W3180879220 hasConceptScore W3180879220C2777740455 @default.
- W3180879220 hasConceptScore W3180879220C2779013556 @default.
- W3180879220 hasConceptScore W3180879220C2779066768 @default.
- W3180879220 hasConceptScore W3180879220C2780849966 @default.
- W3180879220 hasConceptScore W3180879220C29456083 @default.
- W3180879220 hasConceptScore W3180879220C38180746 @default.
- W3180879220 hasConceptScore W3180879220C71924100 @default.
- W3180879220 hasConceptScore W3180879220C86803240 @default.
- W3180879220 hasFunder F4320336588 @default.
- W3180879220 hasLocation W31808792201 @default.
- W3180879220 hasLocation W31808792202 @default.
- W3180879220 hasLocation W31808792203 @default.
- W3180879220 hasOpenAccess W3180879220 @default.
- W3180879220 hasPrimaryLocation W31808792201 @default.